<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-11478R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007360</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Physiology</subject><subject>Physiology/Cardiovascular Physiology and Circulation</subject><subject>Physiology/Cell Signaling</subject></subj-group></article-categories><title-group><article-title>New Insights in the Contribution of Voltage-Gated Na<sub>v</sub> Channels to Rat Aorta Contraction</article-title><alt-title alt-title-type="running-head">Arterial Nav Channels</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fort</surname><given-names>Aur&#x000e9;lie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cordaillat</surname><given-names>Magali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thollon</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Salazar</surname><given-names>Guillermo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mechaly</surname><given-names>Ilana</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Villeneuve</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vilaine</surname><given-names>Jean-Paul</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Richard</surname><given-names>Sylvain</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Virsolvy</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Inserm U637, Universit&#x000e9; Montpellier1 &#x00026; 2, Montpellier, France</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Cardiovascular Division, Institut de Recherches Servier, Suresnes, France</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Inserm U583, Universit&#x000e9; Montpellier2, Montpellier, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Nitabach</surname><given-names>Michael N.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Yale School of Medicine, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>sylvain.richard@inserm.fr</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: IM NV JPV SJR AV. Performed the experiments: AF MC CT GS AV. Analyzed the data: AF MC CT SJR AV. Contributed reagents/materials/analysis tools: IM NV JPV. Wrote the paper: SJR AV.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>7</day><month>10</month><year>2009</year></pub-date><volume>4</volume><issue>10</issue><elocation-id>e7360</elocation-id><history><date date-type="received"><day>4</day><month>7</month><year>2009</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Fort et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Despite increasing evidence for the presence of voltage-gated Na<sup>&#x0002b;</sup> channels (Na<sub>v</sub>) isoforms and measurements of Na<sub>v</sub> channel currents with the patch-clamp technique in arterial myocytes, no information is available to date as to whether or not Na<sub>v</sub> channels play a functional role in arteries. The aim of the present work was to look for a physiological role of Na<sub>v</sub> channels in the control of rat aortic contraction.</p></sec><sec><title>Methodology/Principal Findings</title><p>Na<sub>v</sub> channels were detected in the aortic media by Western blot analysis and double immunofluorescence labeling for Na<sub>v</sub> channels and smooth muscle &#x003b1;-actin using specific antibodies. In parallel, using real time RT-PCR, we identified three Na<sub>v</sub> transcripts: Na<sub>v</sub>1.2, Na<sub>v</sub>1.3, and Na<sub>v</sub>1.5. Only the Na<sub>v</sub>1.2 isoform was found in the intact media and in freshly isolated myocytes excluding contamination by other cell types. Using the specific Na<sub>v</sub> channel agonist veratridine and antagonist tetrodotoxin (TTX), we unmasked a contribution of these channels in the response to the depolarizing agent KCl on rat aortic isometric tension recorded from endothelium-denuded aortic rings. Experimental conditions excluded a contribution of Na<sub>v</sub> channels from the perivascular sympathetic nerve terminals. Addition of low concentrations of KCl (2&#x02013;10 mM), which induced moderate membrane depolarization (e.g., from &#x02212;55.9&#x000b1;1.4 mV to &#x02212;45.9&#x000b1;1.2 mV at 10 mmol/L as measured with microelectrodes), triggered a contraction potentiated by veratridine (100 &#x000b5;M) and blocked by TTX (1 &#x000b5;M). KB-R7943, an inhibitor of the reverse mode of the Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger, mimicked the effect of TTX and had no additive effect in presence of TTX.</p></sec><sec><title>Conclusions/Significance</title><p>These results define a new role for Na<sub>v</sub> channels in arterial physiology, and suggest that the TTX-sensitive Na<sub>v</sub>1.2 isoform, together with the Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger, contributes to the contractile response of aortic myocytes at physiological range of membrane depolarization.</p></sec></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Over the last two decades, there has been increasing evidence for the presence of tetrodotoxin-sensitive (TTX<sub>S</sub>) voltage-gated Na<sup>&#x0002b;</sup> currents (I<sub>Na</sub>) in arterial smooth muscle cells (SMCs). Most of these observations have been made in primary cultured cells derived from large human and mammalian arteries <xref ref-type="bibr" rid="pone.0007360-James1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007360-Jo1">&#x0005b;5&#x0005d;</xref>. I<sub>Na</sub> have also been recorded in freshly isolated vascular myocytes, although the process of enzymatic dissociation is critical, and is a potential limiting factor in recording these currents <xref ref-type="bibr" rid="pone.0007360-BerraRomani1">&#x0005b;6&#x0005d;</xref>. Voltage-gated Na<sup>&#x0002b;</sup> channels (Na<sub>v</sub>) are usually responsible for the initiation and propagation of the action potential in excitable cells including, typically, neurons, skeletal muscle and cardiac cells. However, they could play a different role in arteries. It has been shown that some Na<sub>v</sub> channels regulate intracellular Ca<sup>2&#x0002b;</sup> (&#x0005b;Ca<sup>2&#x0002b;</sup>&#x0005d;<sub>i</sub>) in human coronary myocytes in primary culture. This regulation is effective at baseline and involves the tonic control of Ca<sup>2&#x0002b;</sup> influx <xref ref-type="bibr" rid="pone.0007360-Boccara1">&#x0005b;7&#x0005d;</xref>. Yet, even now, the functional role of Na<sub>v</sub> channels in intact arteries is unknown.</p><p>At the molecular level, Na<sub>v</sub> channels are composed of a membrane-spanning pore-forming &#x003b1; subunit (&#x0223c;260 kDa), which may be associated with different auxiliary &#x003b2;-subunits <xref ref-type="bibr" rid="pone.0007360-Catterall1">&#x0005b;8&#x0005d;</xref>. Nine genes encoding functional Na<sub>v</sub> channel &#x003b1;-subunits (named Na<sub>v</sub>1.1 through Na<sub>v</sub>1.9) have been cloned, electrophysiologically characterized, and exhibit the appropriate ion permeation, voltage sensing and inactivation properties. Four &#x003b2;-subunits, named &#x003b2;1, &#x003b2;2, &#x003b2;3 and &#x003b2;4 have also been cloned and shown to regulate Na<sub>v</sub> channel &#x003b1;-subunit gating and expression levels <xref ref-type="bibr" rid="pone.0007360-Catterall1">&#x0005b;8&#x0005d;</xref>. Most Na<sub>v</sub> channels isoforms can be classified according to their sensitivity to the specific Na<sub>v</sub> channel blocker TTX. TTX-sensitive (TTX<sub>S</sub>) isoforms are inhibited at nanomolar concentrations. They are preferentially expressed in the nervous system (Na<sub>v</sub>1.1, Na<sub>v</sub>1.2, Na<sub>v</sub>1.3, Na<sub>v</sub>1.6, and Na<sub>v</sub>1.7) or in adult skeletal muscle (Na<sub>v</sub>1.4). TTX-resistant (TTX<sub>R</sub>) isoforms (inhibited in the micromolar range) are the cardiac isoform (Na<sub>v</sub>1.5) and isoforms expressed in the peripheral nervous system (Na<sub>v</sub>1.8 and Na<sub>v</sub>1.9). Various gene products coding for Na<sub>v</sub> channels have been detected in arterial myocytes <xref ref-type="bibr" rid="pone.0007360-Jo1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Platoshyn1">&#x0005b;9&#x0005d;</xref>.</p><p>Despite an increasing number of studies providing evidence for the presence of I<sub>Na</sub> in arterial cells, no information is available as to whether or not Na<sub>v</sub> channels play a functional role in arteries. In the present work, we looked for a physiological role of Na<sub>v</sub> channel activity in the control of aortic contraction in the rat. Our results show that the brain-type Na<sub>v</sub>1.2 channel is, surprisingly, expressed in the muscular layer of the aorta, and is likely to contribute to contraction.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Isolation of arteries and myocytes</title><p>The investigation conformed to the guidelines for the Care and Use of Laboratory Animals (NIH, N&#x000b0;.85&#x02013;23, revised 1996) and European directives (96/609/EEC) and was approved by the <italic>Comit&#x000e9; R&#x000e9;gional d'Ethique sur l'exp&#x000e9;rimentation animale</italic> of <italic>Languedoc-Roussillon</italic> on the Use and Care of Animals. Male Sprague-Dawley rats (22&#x02013;25 weeks) were anesthetized with an intraperitoneal injection of pentobarbital (150 mg/kg). The thoracic aorta was removed, immersed in a physiological saline solution (PSS) cleaned and processed for the different studies. The thoracic aorta was removed, immersed in a physiological saline solution (PSS) cleaned and processed for the different studies. Myocytes were isolated by enzymatic dissociation using collagenase type I (1 mg/ml) and elastase (0.5 mg/ml, Sigma) as described before <xref ref-type="bibr" rid="pone.0007360-Bodin1">&#x0005b;10&#x0005d;</xref>. The composition of the PSS was as follows (in mmol/L): 140 NaCL, 5 KCl, 1 MgCl<sub>2</sub>, 0.5 KH<sub>2</sub>PO<sub>4</sub>, 0.5 Na<sub>2</sub>HPO<sub>4</sub>, 2.5 CaCl<sub>2</sub>, 10 HEPES, 10 glucose, pH 7.4.</p></sec><sec id="s2b"><title>Western blotting</title><p>Total protein was extracted from whole tissues (brain and aorta) and the presence of Na<sub>v</sub> channel proteins was determined by Western blot analysis using a rabbit polyclonal anti-Pan-Na<sub>v</sub> channel antibody (Alomone; 1&#x02236;500). A rabbit polyclonal GAPDH antibody (FL:335, Santa Cruz) was used to determine the cellular fraction of the crude protein extract. Tissues were homogenized in ice-cold buffer containing 20 mmol/L Tris-HCl, 150 mmol/L NaCl, 10 mmol/L dithiotreitol and protease inhibitor cocktail (Roche). Proteins (10 &#x000b5;g for brain and 50 &#x000b5;g for aorta) were separated on a 4.5&#x00025; SDS-polyacrylamide gel and transferred to nitrocellulose membranes. Antibody specificity was validated by incubating with the peptide antigen (1 &#x000b5;g peptide for 1 &#x000b5;g antibody). After washing in Tris-buffered saline containing 0.1&#x00025; Tween-20 (TBS-T), membranes were blocked in TBS-T containing 5&#x00025; skimmed milk powder and incubated with the anti-Pan Na<sub>v</sub> channel antibody or polyclonal GAPDH antibody. After washing in TBS-T, membranes were incubated with a horseradish peroxidase-conjugated anti-rabbit secondary antibody (1&#x02236;1000). Bound immunoglobulins were revealed with SuperSignal West Pico chemiluminescent substrate (Pierce) and signal recorded using a Kodak image station. The rabbit polyclonal GAPDH antibody (FL:335, Santa Cruz) was used to estimate the cellular fraction of the crude protein extract on the same blots.</p></sec><sec id="s2c"><title>RNA extraction, end-point RT-PCR and real-time PCR</title><p>Total RNA was extracted from rat aorta or from isolated cells using Tri reagent (Sigma) according to manufacturer's instructions. DNase-treated (DNase I, Invitrogen) total RNA (1&#x02013;2 &#x000b5;g) was transcribed into cDNA using Superscript II reverse transcriptase (Invitrogen) and random primer oligonucleotides (Invitrogen). Gene-specific primers for rat Na<sub>v</sub> channel isoforms, &#x003b1;-actin and GAPDH were designed based on sequences available through PubMed (for sequences see <xref ref-type="table" rid="pone-0007360-t001">Table 1</xref>). End-point PCR reactions were run on 50&#x02013;100 ng cDNA using a HotStartTaq&#x000ae; polymerase (Qiagen). Amplification was carried out as follows: an initial activation step at 95&#x000b0;C for 15 min, followed by 35 cycles of 30 s at 95&#x000b0;C, 1 min at 59&#x000b0;C and 1 min at 72&#x000b0;C, with final extension for 8 min at 72&#x000b0;C. PCR products were visualized under UV light after electrophoresis on 2&#x00025; agarose gels containing ethidium bromide. Negative controls were run without reverse transcriptase. Each primer pair was validated by amplification of total RNA from positive controls (rat brain, heart and skeletal muscle) and direct sequencing of the PCR product (Genome Express). Real-time quantitative PCR was performed in a Light Cycler System (Roche) in combination with the Absolute QPCR SYBR Green Capillary mix (Abgene). After a hot start (15 min at 95&#x000b0;C), the parameters for amplification were: 1 s at 95&#x000b0;C, 5 s at 60&#x000b0;C and 10 s at 72&#x000b0;C for 45 cycles. Primers selected in <xref ref-type="table" rid="pone-0007360-t001">table 1</xref> were of equal efficiency (E<sub>ff</sub>&#x0200a;&#x0003d;&#x0200a;1.9) across the range of template concentrations (1&#x02013;10 ng cDNA). Expression levels normalized with GAPDH were calculated relative to the less abundant isoform (Na<sub>v</sub>1.6) using the E<sub>ff</sub><sup>&#x02212;&#x00394;&#x00394;Ct</sup> method.</p><table-wrap id="pone-0007360-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.t001</object-id><label>Table 1</label><caption><title>Nucleotide sequences of the specific primers used to detect Na<sub>v</sub> channel &#x003b1; and &#x003b2; isoforms by RT-PCR.</title></caption><alternatives><graphic id="pone-0007360-t001-1" xlink:href="pone.0007360.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Isoform</td><td align="left" rowspan="1" colspan="1">Accession number</td><td align="left" rowspan="1" colspan="1">Forward primer</td><td align="left" rowspan="1" colspan="1">Reverse primer</td><td align="left" rowspan="1" colspan="1">Product size (pb)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Nav 1.1</td><td align="left" rowspan="1" colspan="1">X03368</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CATCATCTTCGGCTCGTTCT</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCTTGTCACATAATCGCTCTGG</named-content></td><td align="left" rowspan="1" colspan="1">316</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.2</td><td align="left" rowspan="1" colspan="1">X03639</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCTTCGGCTCATTCTTCACC</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GTTGGTCATCTCCTGACTCTGGT</named-content></td><td align="left" rowspan="1" colspan="1">311</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.3</td><td align="left" rowspan="1" colspan="1">Y00766</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CGGCTCAAAGAAACCTCAGA</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCGAGAGAATCACCACCACA</named-content></td><td align="left" rowspan="1" colspan="1">305</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.4</td><td align="left" rowspan="1" colspan="1">NM_013178</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TGGGAATAGCAGTGATGCTG</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AAGGAGCCCAGGAAGATGAT</named-content></td><td align="left" rowspan="1" colspan="1">228</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.5</td><td align="left" rowspan="1" colspan="1">NM_013125</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GAGAACCCAGACCACGGTTA</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCCTCGGTGTTCCTTCTTGAG</named-content></td><td align="left" rowspan="1" colspan="1">305</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.6</td><td align="left" rowspan="1" colspan="1">L39018</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GTTCATCGGTGTCATCATCG</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CAAGGCAAACATTTTGAGCA</named-content></td><td align="left" rowspan="1" colspan="1">355</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.7</td><td align="left" rowspan="1" colspan="1">AF000368</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTCGGCTCATTCTTCACGTT</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CACTCCCCAGTGAACAGGAT</named-content></td><td align="left" rowspan="1" colspan="1">359</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.8</td><td align="left" rowspan="1" colspan="1">NM_017247</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CACGGATGACAACAGGTCAC</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GATCCCGTCAGGAAATGAGA</named-content></td><td align="left" rowspan="1" colspan="1">151</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav 1.9</td><td align="left" rowspan="1" colspan="1">NM_019265</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCTCCTTGAGCAGACCAAC</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTTATGCACAGCCACTGAGG</named-content></td><td align="left" rowspan="1" colspan="1">222</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav &#x003b2;1</td><td align="left" rowspan="1" colspan="1">NM_017288</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GTGTATGGGATGACCTTCAAA</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GTAGTCGCCAGAGTGG</named-content></td><td align="left" rowspan="1" colspan="1">267</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav &#x003b2;2</td><td align="left" rowspan="1" colspan="1">NM_012877</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GATGCCTGGCTACCTCGCCCT</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AACCTGAAGCTGGAGCGGTTT</named-content></td><td align="left" rowspan="1" colspan="1">276</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav &#x003b2;3</td><td align="left" rowspan="1" colspan="1">NM_139097</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GACTCTGGCCTCTACAC</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCGTCTGACTACCTTGC</named-content></td><td align="left" rowspan="1" colspan="1">260</td></tr><tr><td align="left" rowspan="1" colspan="1">Nav &#x003b2;4</td><td align="left" rowspan="1" colspan="1">NM_001008880</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">ATAACAGCGAAACATCCAGG</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CACGAAGCAAGTGTATCTGC</named-content></td><td align="left" rowspan="1" colspan="1">188</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b2; actin</td><td align="left" rowspan="1" colspan="1">NM_031144</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TACCCCATTGAACACGGC</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TGGGCACAGTGTGGGTGAC</named-content></td><td align="left" rowspan="1" colspan="1">289</td></tr><tr><td align="left" rowspan="1" colspan="1">GAPDH</td><td align="left" rowspan="1" colspan="1">NM_0170008</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AGAACATCATCCCTGCATCC</named-content></td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCCACCACCCTGTTGCTGTA</named-content></td><td align="left" rowspan="1" colspan="1">367</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>Each set of primers was designed from mRNA sequences with the Genbank accession numbers indicated above, using the primer design software Light Cycler Probe Design (Roche). They generated PCR products of the predicted length in base pairs.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2d"><title>Immunohistochemistry</title><p>Double immunofluorescence labeling for Na<sub>v</sub> channels and smooth muscle &#x003b1;-actin was carried out on cryostat sections of rat aorta embedded in OCT (Tissue Tek&#x000ae;), and immersed in liquid N<sub>2</sub>. After fixation in ethanol/acetone (v/v), tissue sections were first blocked with 5&#x00025; normal goat serum (Sigma) in PBS containing 1&#x00025; BSA, then incubated with the first primary antibody, washed with PBS and incubated with the first fluorescent secondary antibody. Sections were then blocked with 5&#x00025; normal horse serum (Sigma), incubated with the second primary antibody and finally incubated with the second fluorescent secondary antibody. Nuclei were counterstained with 5 &#x000b5;mol/L TOTO&#x000ae;-3 iodide (Molecular Probes). Sections were coverslipped with fluorescent mounting medium (DakoCytomation) and visualized using a BioRad MRC-1024 laser scanning confocal imaging system (Montpellier RIO imaging platform). The primary antibodies used were: anti-Pan Na<sub>v</sub> channel antibody for the first labeling step, and a mouse monoclonal anti-smooth muscle &#x003b1;-actin antibody (clone 1A4, Sigma; 1/1000) for the second. Secondary antibodies were, respectively, Texas Red&#x000ae;-conjugated goat anti-rabbit IgG and fluorescein-conjugated horse anti-mouse IgG, both diluted 1/100 (Vector Laboratories). Negative controls followed the same protocol but without primary antibody, or with the inclusion of peptide antigens (1 &#x000b5;g of peptide for 1 &#x000b5;g of antibody).</p></sec><sec id="s2e"><title>Vascular reactivity</title><p>Experiments were performed as previously described <xref ref-type="bibr" rid="pone.0007360-Cordaillat1">&#x0005b;11&#x0005d;</xref>. The aorta was cut into 2&#x02013;3 mm-wide rings. The endothelium was removed by rubbing and the rings were placed in conventional organ bath chambers filled with PSS, maintained at 37&#x000b0;C and continuously bubbled with O<sub>2</sub>. Changes in isometric tension were recorded using an IT1-25 force transducer and an IOX computerized system (EMKA Technologies, Paris, France). After a 60 min equilibration period at a resting tension of 2 g (optimal resting tension), the viability and contractility of each arterial segment was assessed with 1 &#x000b5;mol/L phenylephrine (PE). Acetylcholine causes endothelium-dependent vasorelaxation. Thus the absence of functional endothelium was confirmed on each aortic ring by the lack of response to acetylcholine (1 &#x000b5;mol/L) on top of PE effect. Concentration-response curves were generated by a cumulative increase in the concentration of various vasoconstrictors. The blockade of &#x003b1;<sub>1</sub>-adrenergic receptors was carried out by a 10 min pre-incubation period with 10 &#x000b5;mol/L prazosin. Its efficacy, controlled with 1 &#x000b5;mol/L phenylephrine or with 1 mmol/L tyramine, was maintained even after several wash-outs. Specific protocols are detailed in the legends.</p></sec><sec id="s2f"><title>Membrane potential</title><p>Rings of thoracic aorta (2&#x02013;3 mm long) were cut open along the longitudinal axis and pinned down to the bottom of an experimental chamber, endothelial side upward. All aorta segments were superfused continuously at 5 mL/min with oxygenated PSS (37&#x000b0;C, pH 7.4, bubbled with O<sub>2</sub>). The membrane potential was measured in subintimal vascular smooth muscle cells, after crossing both the endothelial cell layer and the internal elastic laminae, using glass microelectrodes (30&#x02013;40 M&#x003a9;) filled with 3M KCl <xref ref-type="bibr" rid="pone.0007360-Thollon1">&#x0005b;12&#x0005d;</xref>. Recordings were made using a conventional high-impedance amplifier (V 180, Biologic). The membrane potential was monitored on a digital storage oscilloscope (2211, Tektronix). Signals were digitized and analyzed using specific software (EMKA Technologies). After a resting period, aorta preparations were exposed to increasing KCl concentrations, from 5 to 15 mmol/L, during stable recording from one smooth muscle cell. Changes in membrane potential were compared to time-matched recordings performed with PSS. For some experiments, a wash-out step was carried out after exposure to increased K<sup>&#x0002b;</sup> solutions.</p></sec><sec id="s2g"><title>Data analysis</title><p>All data are expressed as mean &#x000b1; standard error of the mean (s.e.m.), for <italic>n</italic> experiments. Data were statistically analyzed using either the Student's t test for unpaired or paired values depending on experimental procedures, or a two-way ANOVA followed by a Bonferroni post-test, as specified in the legends. P values lower than 0.05 were considered significant.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Identification of Na<sub>v</sub> channel isoforms in the rat aorta</title><p>Western blotting with a specific Na<sub>v</sub> channel &#x003b1;-subunit antibody (anti-Pan) showed the presence of Na<sub>v</sub> channel proteins in the rat aorta (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1A</xref>). A positive control from brain tissue revealed a band at around 250 kDa. Antibody specificity was validated in the brain, known to express Na<sub>v</sub> channels highly, by incubating with the peptide antigen which abolished the signal. The observation of similar bands in aortic protein extracts indicated the presence of Na<sub>v</sub> channels. We determined the molecular identity of these Na<sub>v</sub> channels by RT-PCR, using primers specific for each known isoform. Each primer pair yielded a single product with the predicted length and sequence (data not shown) in control tissues (brain, heart and skeletal muscle). In the whole rat aorta, three transcripts were detected: Na<sub>v</sub>1.2, Na<sub>v</sub>1.3 and Na<sub>v</sub>1.5 (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1B</xref>). Only Na<sub>v</sub>1.2 was detected in the media and in freshly isolated aortic myocytes. The four &#x003b2;&#x02212;isoform transcripts were also detected, although the &#x003b2;<sub>4</sub> isoform was not detected in the media (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1B</xref>).</p><fig id="pone-0007360-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.g001</object-id><label>Figure 1</label><caption><title>Identification of Na<sub>v</sub> channels in the rat aorta and isolated vascular myocytes.</title><p>(A) Western blot analysis of protein extracts from control tissues (brain; 10 &#x000b5;g of total protein extract per tissue) and aorta (50 &#x000b5;g of total protein extract per tissue) performed using an anti-Pan Na<sub>v</sub> channel antibody. Labeling specificity was assessed in the brain by pre-incubating the primary antibody with the peptide antigen. Cellular protein content was estimated from the GAPDH signal (lower panel). Arrows indicate the migration of the molecular weight marker (220 and 36 kDa). (B) Analysis of Na<sub>v</sub> transcripts in total RNA extracted from rat aorta, aortic media and freshly isolated SMCs: representative images obtained after end-point RT-PCR. &#x003b2;-actin or GAPDH primers were used as positive controls to validate reverse transcription. The panel at right shows a sample quantification of Na<sub>v</sub> isoform transcripts. The expression of Na<sub>v</sub>1.2, 1.3 and 1.5 was evaluated by quantitative real-time RT-PCR. Transcript levels were normalized to that of the GAPDH housekeeping gene in each sample and compared in the whole aorta, media layer and freshly isolated SMCs. Data are expressed as means &#x000b1;s.e.m. of five experiments, each performed in triplicate. &#x0002a;p&#x0003c;0.05; &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.001, unpaired <italic>t-test</italic>. (C) Immunolocalization of Na<sub>v</sub> channels in aortic tissue. The upper panel represents typical confocal images obtained from successive sections of rat aorta using a 20X objective; (C1) Specific anti-Pan labeling; arrows indicate the endothelium, media and adventitial layers; (C2) negative control without primary antibody; (C3) negative control with the peptide antigen. Lower panels correspond to high magnification (60X objective) images of the inset in C1, showing immunofluorescence staining for Na<sub>v</sub> channels (C4), &#x003b1;-actin (C5), and double immunofluorescence staining with TOTO counterstaining (blue) (C6). <italic>Scale bars</italic> - 50 &#x000b5;m.</p></caption><graphic xlink:href="pone.0007360.g001"/></fig></sec><sec id="s3b"><title>Localization of Na<sub>v</sub> channels</title><p>Aortic tissue sections were double-labeled with an anti-Pan antibody (red fluorescence) and a smooth muscle &#x003b1;-actin antibody (green fluorescence) to examine the localization of Na<sub>v</sub> channels (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>). Red fluorescence was observed in the media (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>1). Labeling specificity was validated using negative controls without primary antibody (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>2) or with the peptide antigen (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>3). Under high magnification, Na<sub>v</sub> channels were found to be homogenously distributed throughout the media (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>4 ) in cells identified as vascular SMCs by green labeling for smooth muscle &#x003b1;-actin (<xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>5 and <xref ref-type="fig" rid="pone-0007360-g001">Fig. 1C</xref>6).</p></sec><sec id="s3c"><title>Effect of veratridine on aortic contraction</title><p>The vasoconstrictors PE, arginin-vasopressin (AVP) and endothelin-1 (ET-1) as well as the depolarizing agent KCl induced a dose-dependent contraction of endothelium-denuded rat aortic rings with similar maximal amplitudes at saturating concentrations (PE: 3.8&#x000b1;0.4 g; AVP: 3.3&#x000b1;0.3 g; ET-1: 4.0&#x000b1;0.6 g; KCl: 3.7&#x000b1;0.9 g). The EC<sub>50</sub> values and mean increases in tension (<xref ref-type="table" rid="pone-0007360-t002">Table 2</xref>) were consistent with previously published data <xref ref-type="bibr" rid="pone.0007360-Eatman1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007360-Zhang1">&#x0005b;15&#x0005d;</xref>. Subsequently, Na<sub>v</sub> channel activity was studied using veratridine. Veratridine is an alkaloid with agonist properties which binds to site 2 of Na<sub>v</sub> channels and causes a dramatic slowing of their inactivation and deactivation, leading to sustained Na<sup>&#x0002b;</sup> influx <xref ref-type="bibr" rid="pone.0007360-Quignard1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Hille1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Catterall2">&#x0005b;17&#x0005d;</xref>. As shown in <xref ref-type="fig" rid="pone-0007360-g002">Figure 2A</xref>, veratridine induced a concentration-dependent increase in tension with an EC<sub>50</sub> value of 34.2&#x000b1;4.8 &#x000b5;mol/L. At saturating concentrations, veratridine induced an increase in tension of 1.2&#x000b1;0.2 g, corresponding to 30&#x00025; of the maximal contraction induced by the vasoconstrictor). The subsequent addition of TTX inhibited the veratridine-induced contraction in a dose-dependent manner with an EC<sub>50</sub> value of 5.7&#x000b1;0.7 nmol/L (<xref ref-type="fig" rid="pone-0007360-g002">Fig. 2B</xref>). Complete recovery was observed after the wash-out of veratridine, and TTX had no effect on the resting tension (data not shown).</p><fig id="pone-0007360-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.g002</object-id><label>Figure 2</label><caption><title>Contractile response of rat aortic rings to veratridine.</title><p>(A) Veratridine-induced vasoconstriction. <italic>Left panel</italic>: typical recordings of the isometric response to cumulative doses of veratridine (vera). The absence of endothelium was first confirmed by the lack of vasorelaxing effect of 1 &#x000b5;mol/L acetylcholine (Ach) on the contraction evoked by a sub maximal concentration of phenylephrine (PE; 1 &#x000b5;mol/L). After washing (W), increasing concentrations of veratridine (arrows), from 5 to 100 &#x000b5;mol/L, were added. <italic>Right panel</italic>: concentration-response curves of veratridine (EC<sub>50</sub>&#x0200a;&#x0003d;&#x0200a;34.2&#x000b1;4.8 &#x000b5;mol/M). (B) Vasorelaxing effect of TTX (1 &#x000b5;mol/L) on the contraction induced by 100 &#x000b5;mol/L veratridine (representative isometric response, <italic>left panel</italic>). The dose-response curve was obtained by addition of cumulative concentrations of TTX (0.1 nmol/L to 1 &#x000b5;mol/L) after maximal contraction was evoked by 100 &#x000b5;mol/L veratridine. Values are expressed as a percentage of the maximal contraction induced by veratridine. (C) Effect of veratridine in the presence of prazosin or suramin plus PPADS (<italic>left panel</italic>). The graph (<italic>right panel</italic>) represents the contractions induced by PE (1 &#x000b5;mol/L), ATP (100 &#x000b5;mol/L) and veratridine (100 &#x000b5;mol/L) under basal conditions or in the presence of either 10 &#x000b5;mol/L prazosin or a cocktail of suramin (300 &#x000b5;mol/L) and PPADS (30 &#x000b5;mol/L). Data are expressed as a percentage of the response induced by PE (1 &#x000b5;mol/L). All values represent means &#x000b1;s.e.m. of five experiments, each performed in triplicate.</p></caption><graphic xlink:href="pone.0007360.g002"/></fig><table-wrap id="pone-0007360-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.t002</object-id><label>Table 2</label><caption><title>Characteristics of the contractile responses of endothelium-denuded aortic rings to various agonists.</title></caption><alternatives><graphic id="pone-0007360-t002-2" xlink:href="pone.0007360.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Agonist</td><td align="left" rowspan="1" colspan="1">EC<sub>50</sub></td><td align="left" rowspan="1" colspan="1">Emax (g)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">KCl</td><td align="left" rowspan="1" colspan="1">8.5&#x000b1;1.1 mmol/L</td><td align="left" rowspan="1" colspan="1">3.70&#x000b1;0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">PE</td><td align="left" rowspan="1" colspan="1">120&#x000b1;30 nmol/L</td><td align="left" rowspan="1" colspan="1">3.75&#x000b1;0.43</td></tr><tr><td align="left" rowspan="1" colspan="1">AVP</td><td align="left" rowspan="1" colspan="1">11.2&#x000b1;2.3 nmol/L</td><td align="left" rowspan="1" colspan="1">3.34&#x000b1;0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">ET-1</td><td align="left" rowspan="1" colspan="1">4.4&#x000b1;1.5 nmol/L</td><td align="left" rowspan="1" colspan="1">4.00&#x000b1;0.62</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><p>The agonists used are KCl, phenylephrine (PE), arginine-vasopressin (AVP), and endothelin-1 (ET-1). <xref ref-type="sec" rid="s3">Results</xref> are presented as E<sub>max</sub>, corresponding to the maximal effect elicited by each agonist expressed in terms of isometric tension (g), and EC<sub>50</sub> values (in mmol/L or nmol/L), indicating the concentration at which 50&#x00025; of the maximal effect is induced. Values represent the mean&#x000b1;s.e.m. of 5 animals, with experiments performed in duplicate.</p></fn></table-wrap-foot></table-wrap><p>To assess any possible contribution of sympathetic neurotransmitters release (norepinephrine and ATP) to the effect of veratridine, we performed experiments in the presence of prazosin, an antagonist of the &#x003b1;<sub>1</sub>-adrenergic receptors responsible for the vasoconstrictive action of norepinephrine, and/or of a cocktail of selective and competitive antagonists of ATP-stimulated responses <xref ref-type="bibr" rid="pone.0007360-Vassort1">&#x0005b;18&#x0005d;</xref>. A saturating concentration of prazosin (10 &#x000b5;mol/L) fully antagonized the potentiating effects of a maximally effective concentration of the &#x003b1;<sub>1</sub>-adrenergic receptor agonist PE (1 &#x000b5;mol/L; <xref ref-type="fig" rid="pone-0007360-g002">Fig. 2C</xref>), and of tyramine (100 &#x000b5;mol/L; data not shown), an indirect sympathomimetic agent which triggers transmitter release from adrenergic terminals and prolongs their action <xref ref-type="bibr" rid="pone.0007360-Barger1">&#x0005b;19&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007360-Muramatsu1">&#x0005b;21&#x0005d;</xref>. While prazosin (10 &#x000b5;mol/L) had no effect <italic>per se</italic>, it abolished the contraction induced by veratridine. A cocktail composed of the P2Y receptor antagonist suramin (300 &#x000b5;mol/L) and the P2X receptor antagonist pyridoxal-phosphate-6-azophenyl-2&#x02032;, 4&#x02032;-disulphonic acid (PPADS; 30 &#x000b5;mol/L), which had no effect <italic>per se</italic>, abolished the vasoconstrictive effect of ATP (100 &#x000b5;mol/L). This cocktail had no effect on the contraction induced by veratridine (<xref ref-type="fig" rid="pone-0007360-g002">Fig. 2C</xref>).</p></sec><sec id="s3d"><title>Na<sub>v</sub> channel activity unmasked by low KCl</title><p>The experiments detailed above show that the activation of &#x003b1;<sub>1</sub>-adrenergic receptors could be involved in the effect of veratridine on aortic contraction, presumably via neuronal Na<sub>v</sub> channel activity and catecholamine release. In order to specifically investigate the functional activity of Na<sub>v</sub> channels at the aortic myocytes level, subsequent experiments were performed in the presence of prazosin (which we have shown to be necessary and sufficient to abolish the effect of veratridine) and, eventually, of the suramin/PPADS cocktail. We also reasoned that the use of massive concentrations of KCl, resulting in large depolarizations, could directly activate Ca<sup>2&#x0002b;</sup> channels. To specifically target Na<sub>v</sub> channels activity and avoid the direct recruitment of L-type Ca<sup>2&#x0002b;</sup> channels, depolarization was induced by the addition of low concentrations of KCl.</p><p><xref ref-type="fig" rid="pone-0007360-g003">Figure 3A</xref> illustrates that, in the presence of prazosin, veratridine (100 &#x000b5;mol/L) potentiates the contraction induced by the addition of 6 mmol/L KCl to the extracellular bath. A similar but smaller effect was seen after the addition of 10 mmol/L KCl. The amplitude of the effect of veratridine depended in fact on the concentration of KCl and followed a bell-curve between 2 and 15 mmol/L KCl. The maximal response was obtained at 6&#x02013;8 mmol/L KCl (<xref ref-type="fig" rid="pone-0007360-g003">Fig. 3C</xref>) and represented 20&#x00025; of the maximal contraction induced by 1 &#x000b5;mol/l PE. Veratridine had no apparent effect at KCl concentrations below 2 mmol/L or above 15 mmol/L.</p><fig id="pone-0007360-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.g003</object-id><label>Figure 3</label><caption><title>Dependence on KCl of contractile response to veratridine and TTX in the presence of prazosin.</title><p>The absence of endothelium was confirmed as described above. Representative recordings of isometric responses to veratridine (vera; 100 &#x000b5;mol/L) (A) or tetrodotoxin (TTX; 1 &#x000b5;mol/L) (B) after contraction induction by KCl (6 and 10 mmol/L) in the presence of 10 &#x000b5;mol/L prazosin (Pz). (C) Summary of results of the experiments described in A and B: the effects of veratridine (100 &#x000b5;mol/L) or TTX (1 &#x000b5;mol/L) on the contraction induced by KCl were expressed as a percentage of maximal contraction induced by PE (1 &#x000b5;mol/L). (D) Effects of TTX expressed as a percentage of KCl-induced contraction. Values represent the mean&#x000b1;s.e.m. of 6 animals, with experiments performed in duplicate. &#x0002a;p&#x0003c;0.05; &#x0002a;&#x0002a;p&#x0003c;0.01; &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.001, paired <italic>t-test</italic>.</p></caption><graphic xlink:href="pone.0007360.g003"/></fig><p><xref ref-type="fig" rid="pone-0007360-g003">Figure 3(B and C)</xref> show that TTX (1 &#x000b5;mol/L) inhibited the contraction induced by the addition of low concentrations of KCl to the bath whereas no effect was observed with concentrations of KCl higher than 15 mmol/L. Thus, the vasorelaxing effects of TTX mirrored the enhancement induced by veratridine between 2 and 15 mmol/L KCl, with maximal inhibition observed at 6&#x02013;8 mmol/L, once again corresponding to 20&#x00025; of the maximal contractile response (<xref ref-type="fig" rid="pone-0007360-g003">Fig. 3C</xref>). Interestingly, these data, expressed as a percentage of KCl-induced contraction (<xref ref-type="fig" rid="pone-0007360-g003">Fig. 3D</xref>), reveal that the contribution of the TTX-sensitive component of contraction to the KCl response decreases monotonically from 100 &#x00025; at 2 mmol/L to 0 &#x00025; at 15 mmol/L. These data suggest that most of the vasoconstrictive response observed at the lowest KCl concentrations is mediated by Na<sub>v</sub> channels. This contribution was confirmed by comparing the response to increasing concentrations of KCl in the presence or absence of TTX (1 &#x000b5;mol/L) (<xref ref-type="fig" rid="pone-0007360-g004">Fig. 4</xref>). TTX prevented the contraction induced by KCl at concentrations below 8 mmol/L whereas contraction was significantly attenuated at concentrations between 8 and 15 mmol/L (<xref ref-type="fig" rid="pone-0007360-g004">Fig. 4</xref>). The EC<sub>50</sub> value for KCl-induced contraction increased from 8.4&#x000b1;0.3 mmol/L to 14.3&#x000b1;0.1 mmol/L in the presence of TTX (<xref ref-type="fig" rid="pone-0007360-g004">Fig. 4B</xref>). When TTX was used to block Na<sub>v</sub> channels, the KCl-induced depolarization triggered contraction via the direct recruitment of Ca<sup>2&#x0002b;</sup> channels.</p><fig id="pone-0007360-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.g004</object-id><label>Figure 4</label><caption><title>Involvement of aortic SMC Na<sub>v</sub> channels in the contractile response to KCl.</title><p>The absence of endothelium was confirmed as described above. After washing and 15 min of incubation with prazosin (Pz; 10 &#x000b5;mol/L), suramin (300 &#x000b5;mol/L) and PPADS (30 &#x000b5;mol/L), increasing concentrations of KCl (1 to 100 mmol/L) were added in the absence or presence of TTX (1 &#x000b5;mol/L). (A) Representative recording of the isometric response. (B) Dose-responses to KCl in the absence (&#x02592;) or in the presence of 1 &#x000b5;mol/L TTX (&#x02022;). Data are expressed as a percentage of the maximal KCl-induced contraction and were analyzed with a non-linear fit function to determine EC<sub>50</sub> values. Values represent means&#x000b1;s.e.m. of 5 animals, with experiments performed in quadruplicate.</p></caption><graphic xlink:href="pone.0007360.g004"/></fig></sec><sec id="s3e"><title>The Na<sup>&#x0002b;</sup>-Ca<sup>2&#x0002b;</sup> exchanger links Na<sub>v</sub> channels activity and contraction</title><p>We next measured the membrane potential of vascular SMCs in aortic preparations, and its variation after the addition of low concentrations of KCl to the extracellular bath <xref ref-type="bibr" rid="pone.0007360-Thollon1">&#x0005b;12&#x0005d;</xref>. The average RMP recorded in basal buffer (which contains 5.0 mmol/L KCL) as a reference, was &#x02212;55.9&#x000b1;1.4 mV (n&#x0200a;&#x0003d;&#x0200a;8). <xref ref-type="fig" rid="pone-0007360-g005">Figure 5A</xref> illustrates the depolarizing effect of low concentrations of KCl, in comparison with stable time-matched recordings performed in control solution. The addition of 5 mmol/L and 10 mmol/L KCl to the bath depolarized the RMP to &#x02212;51.4&#x000b1;1.2 mV (n&#x0200a;&#x0003d;&#x0200a;8) and &#x02212;45.9&#x000b1;1.2 mV (n&#x0200a;&#x0003d;&#x0200a;8) respectively (<xref ref-type="fig" rid="pone-0007360-g005">Fig. 5B</xref>). These values were too negative to open the L-Type Ca<sup>2&#x0002b;</sup> channel which has a threshold above &#x02212;40 mV at physiological concentration of Ca<sup>2&#x0002b;</sup><xref ref-type="bibr" rid="pone.0007360-Richard1">&#x0005b;22&#x0005d;</xref>. To explain the link between Na<sub>v</sub> channel activation and vascular contraction, we tested the participation of the Na<sup>&#x0002b;</sup>-Ca<sup>2&#x0002b;</sup> exchanger by using the blocker KB-R7943 reported to inhibit the reverse mode of exchange (Ca<sup>2&#x0002b;</sup> influx/Na<sup>&#x0002b;</sup> efflux) <xref ref-type="bibr" rid="pone.0007360-Iwamoto1">&#x0005b;23&#x0005d;</xref>. <xref ref-type="fig" rid="pone-0007360-g006">Figure 6</xref> shows that KB-R7943 (1 &#x000b5;mol/L) blocked the contraction induced by low concentrations of KCl, thereby reproducing the inhibitory effects of TTX. In addition, KB-R7943 had no additive effect in presence of TTX (data not shown). Thus, the Na<sup>&#x0002b;</sup> influx mediated by Na<sup>&#x0002b;</sup> channels activates the reverse mode of the Na<sup>&#x0002b;</sup>-Ca<sup>2&#x0002b;</sup> exchanger, which promotes Ca<sup>2&#x0002b;</sup> entry and subsequent contraction.</p><fig id="pone-0007360-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.g005</object-id><label>Figure 5</label><caption><title>Membrane potential determination.</title><p>Membrane potentials were recorded in the SMCs of aortic rings under basal conditions and after addition of low KCl concentrations, using glass microelectrodes. (A) Representative recordings illustrating membrane potential stability in control experiments (upper panel) and depolarizations induced by the cumulative addition of 5 mmol/L KCl (lower panel). (B) Averaged membrane potentials under basal conditions (CTL) and after addition of 5 mmol/L and 10 mmol/L KCl (as described). &#x0002a;p&#x0003c;0.05; &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.001; two-way ANOVA followed by a Bonferroni post-hoc analysis. Values represent means &#x000b1;s.e.m. of 4 animals, with experiments performed in duplicate.</p></caption><graphic xlink:href="pone.0007360.g005"/></fig><fig id="pone-0007360-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007360.g006</object-id><label>Figure 6</label><caption><title>Na<sup>&#x0002b;</sup>-Ca<sup>2&#x0002b;</sup> exchanger activity mediates the aortic contractile response after addition of low KCl concentrations.</title><p>Dose-response curves for KCl-induced aortic contraction in physiological saline solution (CTL;&#x02592;), and in the presence of either 1 &#x000b5;mol/L TTX (&#x02022;) or 1 &#x000b5;mol/L KB-R7943 (&#x025aa;). Data were obtained by the cumulative addition of KCl (1 to 10 mmol/L) to aortic rings pre-incubated with the prazosin (10 &#x000b5;mol/L), suramin (300 &#x000b5;mol/L) and PPADS (30 &#x000b5;mol/L) cocktail.</p></caption><graphic xlink:href="pone.0007360.g006"/></fig></sec></sec><sec id="s4"><title>Discussion</title><p>Voltage-gated I<sub>Na</sub> have been recorded in vascular myocytes <xref ref-type="bibr" rid="pone.0007360-James1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007360-Jo1">&#x0005b;5&#x0005d;</xref>. However, the physiological role of Na<sub>v</sub> channels <italic>in vivo</italic> has remained an open question. Although Na<sub>v</sub> channels in peripheral vascular nerve endings contribute to arterial contraction, our study defines a TTX<sub>S</sub> Na<sub>v</sub> channel isoform (Na<sub>v</sub>1.2) expressed in myocytes of the rat aortic media and provides the first evidence of its contribution to aortic contraction at a physiological range of depolarization.</p><sec id="s4a"><title>Na<sub>v</sub> channels in rat arteries</title><p>We have shown the presence of Na<sub>v</sub> channels in the rat aorta. We identified three mRNA transcripts: two neuronal TTX<sub>S</sub> isoforms (Na<sub>v</sub> 1.2 and Na<sub>v</sub> 1.3), and the cardiac TTX<sub>R</sub> isoform Na<sub>v</sub>1.5. Significantly, only the Na<sub>v</sub>1.2 isoform was present in the rat aortic SMCs. Taken together, these findings are consistent with previous reports establishing the presence of Na<sub>v</sub> isoforms in human and animal arterial SMCs <xref ref-type="bibr" rid="pone.0007360-Platoshyn1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Jo2">&#x0005b;24&#x0005d;</xref>. Na<sub>v</sub> channels were distributed in the membranes, as expected for voltage-gated proteins, and in the cytoplasm of the rat aortic SMCs. Similar cytoplasmic localization has been described before, for example, in the soma of primary vestibular neurons and in macrophages, in relation with Na<sub>v</sub> channel storage or/and trafficking to the membrane <xref ref-type="bibr" rid="pone.0007360-Krzemien1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Carrithers1">&#x0005b;26&#x0005d;</xref>.</p></sec><sec id="s4b"><title>Na<sup>&#x0002b;</sup> channel-dependent contraction originating in the myocytes</title><p>One key finding of our study is evidence of a marked dependence of the contraction of rat aortas upon Na<sub>v</sub> channel activity. The Na<sub>v</sub> channel agonist veratridine triggered a dose-dependent aortic contraction with an EC<sub>50</sub> value of 34.2 &#x000b5;M, consistent with previous observations <xref ref-type="bibr" rid="pone.0007360-Shinjoh1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Shinjoh2">&#x0005b;28&#x0005d;</xref>. This response reflects a genuine effect on TTX-sensitive Na<sub>v</sub> channels, as proven by its specific inhibition by TTX (EC<sub>50</sub>&#x0200a;&#x0003d;&#x0200a;5.7&#x000b1;0.7 nmol/L). Its suppression by the &#x003b1;<sub>1</sub>-adrenergic receptor antagonist prazosin suggested that part of this response is mediated through activation of Na<sub>v</sub> channels in sympathetic perivascular nerve-terminals. Subsequent induction of catecholamines release is known to regulate arterial blood pressure via &#x003b1;<sub>1</sub>-adrenergic receptors in the rat aorta <xref ref-type="bibr" rid="pone.0007360-Digges1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007360-Decker1">&#x0005b;31&#x0005d;</xref>. In line with this view, catecholamines are involved in the intense pressor effect induced by the scorpion toxins TsTX-V and TsTX-1, isolated from <italic>Tityus serrulatus</italic> venom, that act on Na<sub>v</sub> channels <xref ref-type="bibr" rid="pone.0007360-Vasconcelos1">&#x0005b;32&#x0005d;</xref>.</p><p>We defined experimental conditions under which a Na<sub>v</sub> channel-dependent contraction likely to originate in the SMCs was unmasked. In absence of &#x003b1;<sub>1</sub>-adrenergic and ATP receptors stimulation, addition of low concentrations of KCl (2&#x02013;10 mM) triggered a contraction potentiated by veratridine (100 &#x000b5;M) and blocked by TTX (1 &#x000b5;M). It attained up to 20&#x00025; of the maximal contraction induced by potent agonists such as PE, AVP, ET-1 and KCl, and accounted for most of the contraction evoked by low KCl depolarization (<xref ref-type="fig" rid="pone-0007360-g003">Fig. 3D</xref>). It has probably been overlooked in the past, most likely due to the narrow range of KCl concentrations required (2&#x02013;15 mmol/L) to evidence it and the lack of TTX use, essential to its identification. At concentrations higher than 15 mmol/L, KCl-induced depolarization is expected to promote the direct opening of voltage-gated Ca<sup>2&#x0002b;</sup> channels, thereby bypassing Na<sub>v</sub> channels. The lack of an effect of TTX on the aortic resting tension, together with the fact that membrane depolarization induced by the addition of low concentrations of KCl (2&#x02013;15 mmol/L) is required to unmask this component of contraction, reveals that Na<sub>v</sub> channels are closed at physiological RMPs. Our measurement of the RMP (&#x02212;56 mV) is consistent with other reports <xref ref-type="bibr" rid="pone.0007360-Fauaz1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Vanheel1">&#x0005b;34&#x0005d;</xref> and with the estimated activation threshold of the Na<sub>v</sub>1.2 isoform; that is between &#x02212;60 mV and &#x02212;50 mV <xref ref-type="bibr" rid="pone.0007360-Misra1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Rush1">&#x0005b;36&#x0005d;</xref>. Interestingly, the window current determined by the overlap of the steady-state activation and inactivation curves of the Na<sub>v</sub>1.2 isoform is expected to generate a persistent influx of Na<sup>&#x0002b;</sup> between the activation threshold (between &#x02212;60 mV and &#x02212;50 mV) and &#x02212;40 mV <xref ref-type="bibr" rid="pone.0007360-Misra1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007360-Rush1">&#x0005b;36&#x0005d;</xref>. The membrane potentials set by the addition of low concentrations of external KCl (5 mmol/L: &#x02212;51 mV, and 10 mmol/L: &#x02212;46 mV) are consistent with the activation of Na<sub>v</sub> channels in this range of potentials, which thereby enables a sustained window Na<sup>&#x0002b;</sup> influx. These potentials are too negative to account for the activation of rat aortic-SMC L-type Ca<sup>2&#x0002b;</sup> channels that have a threshold of activation above &#x02212;40 mV at physiological concentration of Ca<sup>2&#x0002b;</sup><xref ref-type="bibr" rid="pone.0007360-Richard1">&#x0005b;22&#x0005d;</xref>. The blocking effect of KB-R7943 is in favor of the involvement of the Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger working in reverse mode, which provides the route for Ca<sup>2&#x0002b;</sup> entry (against Na<sup>&#x0002b;</sup> extrusion) and activation of contraction. This interpretation is consistent with our previous report of a Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup>-mediated TTX-sensitive Ca<sup>2&#x0002b;</sup> influx in cultured human coronary myocytes <xref ref-type="bibr" rid="pone.0007360-Boccara1">&#x0005b;7&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Functional significance</title><p>Our results taken as a whole - immunochemistry, RT-PCR and functional studies - suggest that Na<sub>v</sub>1.2 channels in rat aortic myocytes provide a mechanism by which slight depolarization controls arterial contraction. These Na<sub>v</sub> channels are likely to translate small changes in the RMP into a fine-tuning of Ca<sup>2&#x0002b;</sup> entry, thereby inducing moderate contraction consistent with physiological regulation. The activation of aortic SMC Na<sub>v</sub> channels occurs within a narrow window of potentials, thus providing cells with an effective mechanism for the maintenance of elevated &#x0005b;Na<sup>&#x0002b;</sup>&#x0005d;<sub>i</sub>, the induction of Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger activity, and consequently, the entry of Ca<sup>2&#x0002b;</sup> independently of Ca<sup>2&#x0002b;</sup> channels activation. Although the participation of the Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger in vascular SMCs contraction has been described, there is a lack of information regarding the mechanisms leading to its activation by intracellular Na<sup>&#x0002b;</sup>. Our discovery of the control of aortic contraction by Na<sub>v</sub> channels and its sensitivity to KB-R7943 provides an excellent candidate for such a mechanism. Vascular Na<sub>v</sub> channels may thus be involved in critical pathophysiological situations and contribute to the role of the Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger in vasoconstriction <xref ref-type="bibr" rid="pone.0007360-Iwamoto2">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007360-Blaustein1">&#x0005b;39&#x0005d;</xref>.</p><p><bold>In summary</bold>, our study provides the first evidence of a TTX-sensitive component of tension activated by KCl-induced depolarization in the aorta, with the unexpected conclusion that the brain-type Na<sub>v</sub>1.2 isoform is involved in this process. The Na<sup>&#x0002b;</sup>-dependent activation of the reverse mode of the Na<sup>&#x0002b;</sup>/Ca<sup>2&#x0002b;</sup> exchanger provides the necessary link to the influx of Ca<sup>2&#x0002b;</sup> and the subsequent contraction of myocytes within the physiological range of membrane depolarizations. The description of a TTX-sensitive contraction originating in vascular myocytes expressing the Na<sub>v</sub>1.2 isoform constitutes a major and novel discovery.</p></sec></sec></body><back><ack><p>We thank Dr. G. Vassort for helpful discussion and Dr S. Rasika of Gap Junction (<ext-link ext-link-type="uri" xlink:href="http://www.gap-junction.com">www.gap-junction.com</ext-link>) for assistance with English editing.</p></ack><ref-list><title>References</title><ref id="pone.0007360-James1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>AF</given-names></name><name><surname>Okada</surname><given-names>T</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name></person-group><year>1995</year><article-title>A fast transient outward current in cultured cells from human pulmonary artery smooth muscle.</article-title><source>Am J Physiol</source><volume>268</volume><fpage>H2358</fpage><lpage>2365</lpage><pub-id pub-id-type="pmid">7611488</pub-id></mixed-citation></ref><ref id="pone.0007360-Quignard1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quignard</surname><given-names>JF</given-names></name><name><surname>Ryckwaert</surname><given-names>F</given-names></name><name><surname>Albat</surname><given-names>B</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name></person-group><year>1997</year><article-title>A novel tetrodotoxin-sensitive Na&#x0002b; current in cultured human coronary myocytes.</article-title><source>Circ Res</source><volume>80</volume><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">9048658</pub-id></mixed-citation></ref><ref id="pone.0007360-Cox1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>RH</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Tulenko</surname><given-names>TN</given-names></name></person-group><year>1998</year><article-title>Voltage-gated sodium channels in human aortic smooth muscle cells.</article-title><source>J Vasc Res</source><volume>35</volume><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">9789111</pub-id></mixed-citation></ref><ref id="pone.0007360-Choby1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choby</surname><given-names>C</given-names></name><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Boccara</surname><given-names>G</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name></person-group><year>2000</year><article-title>Evidence for tetrodotoxin-sensitive sodium currents in primary cultured myocytes from human, pig and rabbit arteries.</article-title><source>Pflugers Arch</source><volume>440</volume><fpage>149</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">10864008</pub-id></mixed-citation></ref><ref id="pone.0007360-Jo1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>T</given-names></name><name><surname>Iida</surname><given-names>H</given-names></name><name><surname>Kishida</surname><given-names>S</given-names></name><name><surname>Imuta</surname><given-names>H</given-names></name><name><surname>Oonuma</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>Acute and chronic effects of eicosapentaenoic acid on voltage-gated sodium channel expressed in cultured human bronchial smooth muscle cells.</article-title><source>Biochem Biophys Res Commun</source><volume>331</volume><fpage>1452</fpage><lpage>1459</lpage><pub-id pub-id-type="pmid">15883037</pub-id></mixed-citation></ref><ref id="pone.0007360-BerraRomani1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berra-Romani</surname><given-names>R</given-names></name><name><surname>Blaustein</surname><given-names>MP</given-names></name><name><surname>Matteson</surname><given-names>DR</given-names></name></person-group><year>2005</year><article-title>TTX-sensitive voltage-gated Na&#x0002b; channels are expressed in mesenteric artery smooth muscle cells.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>289</volume><fpage>H137</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">15961372</pub-id></mixed-citation></ref><ref id="pone.0007360-Boccara1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccara</surname><given-names>G</given-names></name><name><surname>Choby</surname><given-names>C</given-names></name><name><surname>Frapier</surname><given-names>JM</given-names></name><name><surname>Quignard</surname><given-names>JF</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name><etal/></person-group><year>1999</year><article-title>Regulation of Ca2&#x0002b; homeostasis by atypical Na&#x0002b; currents in cultured human coronary myocytes.</article-title><source>Circ Res</source><volume>85</volume><fpage>606</fpage><lpage>613</lpage><pub-id pub-id-type="pmid">10506485</pub-id></mixed-citation></ref><ref id="pone.0007360-Catterall1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name><name><surname>Goldin</surname><given-names>AL</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><year>2003</year><article-title>International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels.</article-title><source>Pharmacol Rev</source><volume>55</volume><fpage>575</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">14657413</pub-id></mixed-citation></ref><ref id="pone.0007360-Platoshyn1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platoshyn</surname><given-names>O</given-names></name><name><surname>Remillard</surname><given-names>CV</given-names></name><name><surname>Fantozzi</surname><given-names>I</given-names></name><name><surname>Sison</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>JX</given-names></name></person-group><year>2005</year><article-title>Identification of functional voltage-gated Na(&#x0002b;) channels in cultured human pulmonary artery smooth muscle cells.</article-title><source>Pflugers Arch</source><volume>451</volume><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">16052353</pub-id></mixed-citation></ref><ref id="pone.0007360-Bodin1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodin</surname><given-names>P</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name><name><surname>Travo</surname><given-names>C</given-names></name><name><surname>Berta</surname><given-names>P</given-names></name><name><surname>Stoclet</surname><given-names>JC</given-names></name><etal/></person-group><year>1991</year><article-title>Responses of subcultured rat aortic smooth muscle myocytes to vasoactive agents and KCl-induced depolarization.</article-title><source>Am J Physiol</source><volume>260</volume><fpage>C151</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">1846268</pub-id></mixed-citation></ref><ref id="pone.0007360-Cordaillat1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordaillat</surname><given-names>M</given-names></name><name><surname>Fort</surname><given-names>A</given-names></name><name><surname>Virsolvy</surname><given-names>A</given-names></name><name><surname>Elghozi</surname><given-names>JL</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Nitric oxide pathway counteracts enhanced contraction to membrane depolarization in aortic rings of rats on high-sodium diet.</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>292</volume><fpage>R1557</fpage><lpage>1562</lpage><pub-id pub-id-type="pmid">17185406</pub-id></mixed-citation></ref><ref id="pone.0007360-Thollon1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thollon</surname><given-names>C</given-names></name><name><surname>Bidouard</surname><given-names>JP</given-names></name><name><surname>Cambarrat</surname><given-names>C</given-names></name><name><surname>Delescluse</surname><given-names>I</given-names></name><name><surname>Villeneuve</surname><given-names>N</given-names></name><etal/></person-group><year>1999</year><article-title>Alteration of endothelium-dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium.</article-title><source>Circ Res</source><volume>84</volume><fpage>371</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">10066670</pub-id></mixed-citation></ref><ref id="pone.0007360-Eatman1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eatman</surname><given-names>D</given-names></name><name><surname>Stallone</surname><given-names>JN</given-names></name><name><surname>Rutecki</surname><given-names>GW</given-names></name><name><surname>Whittier</surname><given-names>FC</given-names></name></person-group><year>1998</year><article-title>Sex differences in extracellular and intracellular calcium-mediated vascular reactivity to vasopressin in rat aorta.</article-title><source>Eur J Pharmacol</source><volume>361</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">9865510</pub-id></mixed-citation></ref><ref id="pone.0007360-Baluchnejadmojarad1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baluchnejadmojarad</surname><given-names>T</given-names></name><name><surname>Roghani</surname><given-names>M</given-names></name><name><surname>Imani</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Protective effect of enalapril on vascular reactivity of the rat aorta.</article-title><source>Vascul Pharmacol</source><volume>40</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">15063834</pub-id></mixed-citation></ref><ref id="pone.0007360-Zhang1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XF</given-names></name><name><surname>Iwamuro</surname><given-names>Y</given-names></name><name><surname>Enoki</surname><given-names>T</given-names></name><name><surname>Okazawa</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><etal/></person-group><year>1999</year><article-title>Pharmacological characterization of Ca2&#x0002b; entry channels in endothelin-1-induced contraction of rat aorta using LOE 908 and SK&#x00026;F 96365.</article-title><source>Br J Pharmacol</source><volume>127</volume><fpage>1388</fpage><lpage>1398</lpage><pub-id pub-id-type="pmid">10455288</pub-id></mixed-citation></ref><ref id="pone.0007360-Hille1"><label>16</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hille</surname><given-names>B</given-names></name></person-group><year>1992</year><article-title>Ionic channels of excitable membranes.</article-title><publisher-loc>Sunderland</publisher-loc><publisher-name>Sinauer Associates Inc</publisher-name></mixed-citation></ref><ref id="pone.0007360-Catterall2"><label>17</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><year>1995</year><article-title>Molecular analysis of voltage-gated sodium channels in the heart and other tissues.</article-title><person-group person-group-type="editor"><name><surname>Zipes</surname><given-names>D</given-names></name><name><surname>Jalife</surname><given-names>J</given-names></name></person-group><source>Cardiac Electrophysiology From Cell to Bedside, 2nd edition ed</source><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>WB Saunders Company.</publisher-name><fpage>1</fpage><lpage>11</lpage></mixed-citation></ref><ref id="pone.0007360-Vassort1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassort</surname><given-names>G</given-names></name></person-group><year>2001</year><article-title>Adenosine 5&#x02032;-triphosphate: a P2-purinergic agonist in the myocardium.</article-title><source>Physiol Rev</source><volume>81</volume><fpage>767</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">11274344</pub-id></mixed-citation></ref><ref id="pone.0007360-Barger1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barger</surname><given-names>G</given-names></name><name><surname>Dale</surname><given-names>HH</given-names></name></person-group><year>1910</year><article-title>Chemical structure and sympathomimetic action of amines.</article-title><source>J Physiol</source><volume>41</volume><fpage>19</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">16993040</pub-id></mixed-citation></ref><ref id="pone.0007360-Leenen1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leenen</surname><given-names>FH</given-names></name><name><surname>Klement</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>B</given-names></name></person-group><year>1992</year><article-title>Dietary sodium restriction and pressor responsiveness to tyramine in spontaneously hypertensive rats.</article-title><source>J Hypertens</source><volume>10</volume><fpage>929</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">1328374</pub-id></mixed-citation></ref><ref id="pone.0007360-Muramatsu1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>I</given-names></name></person-group><year>1987</year><article-title>The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study.</article-title><source>Br J Pharmacol</source><volume>91</volume><fpage>467</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">3038238</pub-id></mixed-citation></ref><ref id="pone.0007360-Richard1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>S</given-names></name><name><surname>Neveu</surname><given-names>D</given-names></name><name><surname>Carnac</surname><given-names>G</given-names></name><name><surname>Bodin</surname><given-names>P</given-names></name><name><surname>Travo</surname><given-names>P</given-names></name><etal/></person-group><year>1992</year><article-title>Differential expression of voltage-gated Ca(2&#x0002b;)-currents in cultivated aortic myocytes.</article-title><source>Biochim Biophys Acta</source><volume>1160</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">1329983</pub-id></mixed-citation></ref><ref id="pone.0007360-Iwamoto1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>T</given-names></name></person-group><year>2004</year><article-title>Forefront of Na&#x0002b;/Ca2&#x0002b; exchanger studies: molecular pharmacology of Na&#x0002b;/Ca2&#x0002b; exchange inhibitors.</article-title><source>J Pharmacol Sci</source><volume>96</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15359084</pub-id></mixed-citation></ref><ref id="pone.0007360-Jo2"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>T</given-names></name><name><surname>Nagata</surname><given-names>T</given-names></name><name><surname>Iida</surname><given-names>H</given-names></name><name><surname>Imuta</surname><given-names>H</given-names></name><name><surname>Iwasawa</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Voltage-gated sodium channel expressed in cultured human smooth muscle cells: involvement of SCN9A.</article-title><source>FEBS Lett</source><volume>567</volume><fpage>339</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">15178348</pub-id></mixed-citation></ref><ref id="pone.0007360-Krzemien1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krzemien</surname><given-names>DM</given-names></name><name><surname>Schaller</surname><given-names>KL</given-names></name><name><surname>Levinson</surname><given-names>SR</given-names></name><name><surname>Caldwell</surname><given-names>JH</given-names></name></person-group><year>2000</year><article-title>Immunolocalization of sodium channel isoform NaCh6 in the nervous system.</article-title><source>J Comp Neurol</source><volume>420</volume><fpage>70</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">10745220</pub-id></mixed-citation></ref><ref id="pone.0007360-Carrithers1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrithers</surname><given-names>MD</given-names></name><name><surname>Chatterjee</surname><given-names>G</given-names></name><name><surname>Carrithers</surname><given-names>LM</given-names></name><name><surname>Offoha</surname><given-names>R</given-names></name><name><surname>Iheagwara</surname><given-names>U</given-names></name><etal/></person-group><year>2009</year><article-title>Regulation of podosome formation in macrophages by a novel splice variant of the sodium channel SCN8A.</article-title><source>J Biol Chem</source><volume>284(12)</volume><fpage>8114</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">19136557</pub-id></mixed-citation></ref><ref id="pone.0007360-Shinjoh1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinjoh</surname><given-names>M</given-names></name><name><surname>Nakaki</surname><given-names>T</given-names></name><name><surname>Otsuka</surname><given-names>Y</given-names></name><name><surname>Sasakawa</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>R</given-names></name></person-group><year>1991</year><article-title>Vascular smooth muscle contraction induced by Na&#x0002b; channel activators, veratridine and batrachotoxin.</article-title><source>Eur J Pharmacol</source><volume>205</volume><fpage>199</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">1667387</pub-id></mixed-citation></ref><ref id="pone.0007360-Shinjoh2"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinjoh</surname><given-names>M</given-names></name><name><surname>Nakaki</surname><given-names>T</given-names></name><name><surname>Otsuka</surname><given-names>Y</given-names></name><name><surname>Sasakawa</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>R</given-names></name></person-group><year>1992</year><article-title>Contraction of vascular smooth muscle by Na&#x0002b; channel activators: involvement of Ca2&#x0002b; channels.</article-title><source>Jpn J Pharmacol</source><volume>58</volume><issue>Suppl 2</issue><fpage>376P</fpage></mixed-citation></ref><ref id="pone.0007360-Digges1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digges</surname><given-names>KG</given-names></name><name><surname>Summers</surname><given-names>RJ</given-names></name></person-group><year>1983</year><article-title>Effects of yohimbine stereoisomers on contractions of rat aortic strips produced by agonists with different selectivity for alpha 1- and alpha 2-adrenoceptors.</article-title><source>Eur J Pharmacol</source><volume>96</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">6141061</pub-id></mixed-citation></ref><ref id="pone.0007360-Macia1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macia</surname><given-names>RA</given-names></name><name><surname>Matthews</surname><given-names>WD</given-names></name><name><surname>Lafferty</surname><given-names>J</given-names></name><name><surname>DeMarinis</surname><given-names>RM</given-names></name></person-group><year>1984</year><article-title>Assessment of alpha-adrenergic receptor subtypes in isolated rat aortic segments.</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><volume>325</volume><fpage>306</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">6145102</pub-id></mixed-citation></ref><ref id="pone.0007360-Decker1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>N</given-names></name><name><surname>Ehrhardt</surname><given-names>JD</given-names></name><name><surname>Leclerc</surname><given-names>G</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><year>1984</year><article-title>Postjunctional alpha-adrenoceptors. Alpha 1 and alpha 2 subtypes in rat vasculature in vitro and in vivo.</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><volume>326</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">6147758</pub-id></mixed-citation></ref><ref id="pone.0007360-Vasconcelos1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>F</given-names></name><name><surname>Lanchote</surname><given-names>VL</given-names></name><name><surname>Bendhack</surname><given-names>LM</given-names></name><name><surname>Giglio</surname><given-names>JR</given-names></name><name><surname>Sampaio</surname><given-names>SV</given-names></name><etal/></person-group><year>2005</year><article-title>Effects of voltage-gated Na&#x0002b; channel toxins from Tityus serrulatus venom on rat arterial blood pressure and plasma catecholamines.</article-title><source>Comp Biochem Physiol C Toxicol Pharmacol</source><volume>141</volume><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15996531</pub-id></mixed-citation></ref><ref id="pone.0007360-Fauaz1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauaz</surname><given-names>G</given-names></name><name><surname>Feres</surname><given-names>T</given-names></name><name><surname>Borges</surname><given-names>AC</given-names></name><name><surname>Paiva</surname><given-names>TB</given-names></name></person-group><year>2000</year><article-title>Alpha-2 adrenoceptors are present in rat aorta smooth muscle cells, and their action is mediated by ATP-sensitive K(&#x0002b;) channels.</article-title><source>Br J Pharmacol</source><volume>131</volume><fpage>788</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">11030729</pub-id></mixed-citation></ref><ref id="pone.0007360-Vanheel1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanheel</surname><given-names>B</given-names></name><name><surname>Van de Voorde</surname><given-names>J</given-names></name><name><surname>Leusen</surname><given-names>I</given-names></name></person-group><year>1994</year><article-title>Contribution of nitric oxide to the endothelium-dependent hyperpolarization in rat aorta.</article-title><source>J Physiol</source><volume>475</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">8021834</pub-id></mixed-citation></ref><ref id="pone.0007360-Misra1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>SN</given-names></name><name><surname>Kahlig</surname><given-names>KM</given-names></name><name><surname>George AL</surname><suffix>Jr</suffix></name></person-group><year>2008</year><article-title>Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures.</article-title><source>Epilepsia</source><volume>49</volume><fpage>1535</fpage><lpage>1545</lpage><pub-id pub-id-type="pmid">18479388</pub-id></mixed-citation></ref><ref id="pone.0007360-Rush1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rush</surname><given-names>AM</given-names></name><name><surname>Dib-Hajj</surname><given-names>SD</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><year>2005</year><article-title>Electrophysiological properties of two axonal sodium channels, Nav1.2 and Nav1.6, expressed in mouse spinal sensory neurones.</article-title><source>J Physiol</source><volume>564</volume><fpage>803</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">15760941</pub-id></mixed-citation></ref><ref id="pone.0007360-Iwamoto2"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>T</given-names></name><name><surname>Kita</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Blaustein</surname><given-names>MP</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><etal/></person-group><year>2004</year><article-title>Salt-sensitive hypertension is triggered by Ca2&#x0002b; entry via Na&#x0002b;/Ca2&#x0002b; exchanger type-1 in vascular smooth muscle.</article-title><source>Nat Med</source><volume>10</volume><fpage>1193</fpage><lpage>1199</lpage><pub-id pub-id-type="pmid">15475962</pub-id></mixed-citation></ref><ref id="pone.0007360-Raina1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raina</surname><given-names>H</given-names></name><name><surname>Ella</surname><given-names>SR</given-names></name><name><surname>Hill</surname><given-names>MA</given-names></name></person-group><year>2008</year><article-title>Decreased activity of the smooth muscle Na&#x0002b;/Ca2&#x0002b; exchanger impairs arteriolar myogenic reactivity.</article-title><source>J Physiol</source><volume>586</volume><fpage>1669</fpage><lpage>1681</lpage><pub-id pub-id-type="pmid">18218677</pub-id></mixed-citation></ref><ref id="pone.0007360-Blaustein1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaustein</surname><given-names>MP</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Raina</surname><given-names>H</given-names></name><etal/></person-group><year>2009</year><article-title>The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.</article-title><source>Hypertension</source><volume>53</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">19104005</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This research was funded by INSERM (Institut National de la Sante et de la Recherche Medicale; <ext-link ext-link-type="uri" xlink:href="http://www.inserm.fr">http://www.inserm.fr</ext-link>) and University of Montpellier 1 (<ext-link ext-link-type="uri" xlink:href="http://www.univ-montp1.fr">http://www.univ-montp1.fr</ext-link>), and was supported by a grant from Institut de Recherches Internationales Servier (Courbevoie, France; ADIR No.04222A10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>